Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot placebo-controlled trial

OBJECTIVE: Obsessive-compulsive disorder (OCD) affects approximately 2.5% of the population and is associated with significant morbidity. Many patients receive little benefit from the best available treatments, and even those who do respond often suffer from significant residual symptoms. Convergent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Psychiatry
Hauptverfasser: Pittenger, Christopher, Bloch, Michael H., Wasylink, Suzanne, Billingslea, Eileen, Simpson, Ryan, Jakubovski, Ewgeni, Kelmendi, Ben, Sanacora, Gerard, Coric, Vladimir
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2015
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4560666/
https://ncbi.nlm.nih.gov/pubmed/26214725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09123
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge